SUNINAT 50MG
DESCRIPTION
Suninat 50mg is sold under the Suninat 50mg capsules brand nameSuninat 50mg Suninat which is needed to treat a gastrointestinal stromal tumor (GIST) after other medicines (e.g., imatinib) did not work very well.Suninat 50mg capsules belongs to the Suninat 50mg capsules group of medicines Suninat 50mg capsules known as antitumorSuninat 50mg medication. It prevents Suninat 50mg the development of cancer cells, which are eventually damaged.
Suninat 50mg is a prescription drugsSuninat 50mg capsules which is used under Suninat 50mg the guidance of medical practioners
 |
| suninat 50mg |
INDICATION
Suninat 50mg capsules is prescribed Suninat 50mg for the therapy of advancedSuninat 50mg capsules renal cell carcinoma as well as the treatment ofSuninat 50mg capsules gastrointestinal stromal tumor after disease progression Suninat 50mg capsules on orSuninat 50mg intolerance to imatinib mesylate.MECHANISM OF ACTION
SunitinibSuninat 50mg shows antitumor andSuninat 50mg capsules antiangiogenic properties by prohibiting multiple receptor Suninat 50mg capsules tyrosine kinases, Suninat 50mg containing platelet-derived growth factors (PDGFRα and PDGFRβ), vascular endothelial growth factorsSuninat 50mg capsules (VEGFR1, VEGFR2, and VEGFR3), Suninat 50mg capsules FMS-like tyrosine kinase-3 (FLT3), colony-stimulating factor type 1 (CSF-1R), and glial cell-line-derived neurotrophic factor receptor (RET).PRODUCT DETAILS
Brand :SuninatIngredients : Sunitinib
Strength : 50mg
Manufactured : Natco Pharma Ltd
Package : 28 capsules in a bottle
PRICE:Suninat 50mg ,Suninat 50mg capsules
ADME
The prescribed dose for Suninat 50mg capsules Gastrointestinal Stromal Suninat 50mg capsules Tumor is 50 mg PO qDay for 4 weeks, continued by 2 weeks drug-free, repeat cycle.
The prescribed dose for Renal Cell Suninat 50mg capsules Carcinoma is 50 mg PO qDay for 4 weeks, followed Suninat 50mg capsules by 2 weeks drug-free, repeat cycle.
Adjuvant treatment of RCC :
• Prescribed for the adjuvant therapySuninat 50mg capsules of adult patients at Suninat 50mg capsules maximum risk of relapsed RCC following nephrectomy
• The PrescribedSuninat 50mg capsules dose is 50 mg PO qDay for 4 weeks,Suninat 50mg continued by 2 weeks drug-free, repeat cycle for a maximum of nineSuninat 50mg capsules 6-week cycles totally
Pancreatic Neuroendocrine Tumor :
Necessary for progress,Suninat 50mg capsules well-differentiated Suninat 50mg capsules pancreatic neuroendocrine tumor (pNET) in patients with unresectable locally advanced or metastatic disease
The prescribed doseSuninat 50mg for Pancreatic NeuroendocrineSuninat 50mg capsules Tumor is 37.5 mg PO qDay continuously without a scheduled off-treatment period
• While using of Suninat 50mg capsules will have ImpairedSuninat 50mg capsules wound healing resulted; temporary interfere with treatment recommended if go through major surgical procedures
• When treatment Suninat Suninat 50mg capsules 50mg will causes severeSuninat 50mg capsules hepatotoxicity involving liver failure; checkSuninat 50mg liver function tests before starting treatment.
• When treatment Suninat 50mg Haemorrhagic events involving tumor-related haemorrhage resulted; test the serial complete blood counts and physical examinations
• When Suninat 50mg capsules treatment Suninat 50mg, Adrenal haemorrhage occurredSuninat 50mg capsules in animal studies; check the adrenal function in case of Suninat 50mg capsules stress such as surgery, trauma or severe infection
• While on treatment Suninat 50mg capsules with Suninat 50mg Suninat 50mg, regulateurine protein; prohibit treatment for 24-hr urine protein ≥3 g; discontinue for repeat episodes of proteinSuninat 50mg capsules ≥3 g despite dose reductions or nephrotic syndrome
Duration of maximumSuninat 50mg capsules plasma concentration Suninat 50mg capsules of sunitinib is between 6 and 12 hours
EliminationSuninat 50mg capsules of Suninat mainlyviaSuninat 50mg capsules feces 61% and renal excretion is 16% of administrated dose.
Sunitinib half-life is 40 – 60 hours
DOSAGE MANAGEMENT
Duration of maximumSuninat 50mg capsules plasma concentration Suninat 50mg capsules of sunitinib is between 6 and 12 hours
EliminationSuninat 50mg capsules of Suninat mainlyviaSuninat 50mg capsules feces 61% and renal excretion is 16% of administrated dose.
Sunitinib half-life is 40 – 60 hours
DOSAGE MANAGEMENT
The prescribed dose for Suninat 50mg capsules Gastrointestinal Stromal Suninat 50mg capsules Tumor is 50 mg PO qDay for 4 weeks, continued by 2 weeks drug-free, repeat cycle.
The prescribed dose for Renal Cell Suninat 50mg capsules Carcinoma is 50 mg PO qDay for 4 weeks, followed Suninat 50mg capsules by 2 weeks drug-free, repeat cycle.
Adjuvant treatment of RCC :
• Prescribed for the adjuvant therapySuninat 50mg capsules of adult patients at Suninat 50mg capsules maximum risk of relapsed RCC following nephrectomy
• The PrescribedSuninat 50mg capsules dose is 50 mg PO qDay for 4 weeks,Suninat 50mg continued by 2 weeks drug-free, repeat cycle for a maximum of nineSuninat 50mg capsules 6-week cycles totally
Pancreatic Neuroendocrine Tumor :
Necessary for progress,Suninat 50mg capsules well-differentiated Suninat 50mg capsules pancreatic neuroendocrine tumor (pNET) in patients with unresectable locally advanced or metastatic disease
The prescribed doseSuninat 50mg for Pancreatic NeuroendocrineSuninat 50mg capsules Tumor is 37.5 mg PO qDay continuously without a scheduled off-treatment period
PRECAUSION
• While using of Suninat 50mg capsules, Hypothyroidism occurred;Suninat 50mg capsules check the baseline thyroid function in patients withSuninat 50mg hypothyroidism or hyperthyroidism and treat per standard medical practice before to initiating treatment• While using of Suninat 50mg capsules will have ImpairedSuninat 50mg capsules wound healing resulted; temporary interfere with treatment recommended if go through major surgical procedures
• When treatment Suninat Suninat 50mg capsules 50mg will causes severeSuninat 50mg capsules hepatotoxicity involving liver failure; checkSuninat 50mg liver function tests before starting treatment.
• When treatment Suninat 50mg Haemorrhagic events involving tumor-related haemorrhage resulted; test the serial complete blood counts and physical examinations
• When Suninat 50mg capsules treatment Suninat 50mg, Adrenal haemorrhage occurredSuninat 50mg capsules in animal studies; check the adrenal function in case of Suninat 50mg capsules stress such as surgery, trauma or severe infection
• While on treatment Suninat 50mg capsules with Suninat 50mg Suninat 50mg, regulateurine protein; prohibit treatment for 24-hr urine protein ≥3 g; discontinue for repeat episodes of proteinSuninat 50mg capsules ≥3 g despite dose reductions or nephrotic syndrome
SIDE EFFECT
Common side effects :
Hives, Breathing difficultySuninat 50mg capsules , Sore throat, Suninat 50mg Skin pain,Suninat 50mg capsules Red or Purple skin rash Upper stomach pain, Itching, Tried feeling, Suninat 50mg capsules Decreased appetite,Suninat 50mg capsules Dark urine, Jaundice.Serious side effects :
Tiredness, decreasedSuninat 50mg capsules urination, Slow heart rate.Suninat 50mg capsules Thyroid problem Swelling in Suninat 50mg capsules ankles or feet, Shortness of breath, Unusual bruising, Muscle Suninat 50mg cramps, Fast heart beats, Sudden dizziness
EMAIL ID : millionhealthpharmaceuticals@gmail.com
PHONE NO : +91-9940472902
No comments:
Post a Comment